Proposals for prevention and management of steroid-induced osteoporosis in children and adolescents

Journal of Paediatrics and Child Health

Volumn 41, Issue 11, 2005, Pages 553-557

  Brown, J J ^a   Zacharin, M R ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Bisphosphonate; Bone mineral density; Bone resorption; Glucocorticoid; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID; INFLIXIMAB; STEROID; VITAMIN D;

ADOLESCENT; BONE DENSITY; CALCIUM METABOLISM; CHILD; CHILD GROWTH; CHILD NUTRITION; CHRONIC DISEASE; CLINICAL PRACTICE; CORTICOSTEROID INDUCED OSTEOPOROSIS; EVIDENCE BASED MEDICINE; EXERCISE; HUMAN; OSTEOLYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBERTY; REVIEW; VITAMIN D METABOLISM; AUSTRALIA; CHEMICALLY INDUCED DISORDER; CHILD DEVELOPMENT; DRUG EFFECT; OSTEOPOROSIS; PHYSIOLOGY; PUBLIC HEALTH;

ADOLESCENT; AUSTRALIA; BONE DENSITY; BONE RESORPTION; CHILD; CHILD DEVELOPMENT; DIPHOSPHONATES; GLUCOCORTICOIDS; HUMANS; NATIONAL HEALTH PROGRAMS; OSTEOPOROSIS;

EID: 33644838620     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2005.00718.x     Document Type: Review

References (58)

1. Slemenda CW, Reister TK, Hui SL, Miller JZ, Christian JC, Johnston CC Jr. Influences on skeletal mineralization in children and adolescents: Evidence for varying effects of sexual maturation and physical activity. J. Pediatt. 1994 125 (2 201 7.
2. Wark J. Osteoporotic fracture: Background and prevention strategies. Maturitas 1996 23 : 2.
3. Ribot C, Tremollieres F, Pouilles JM. Late consequences of a low peak bone mass. Acta Paediatr. Suppl. 1995 411 : 31 5.
4. Seeman E. Perspective: From density to structure: Growing up and growing old on the surfaces of bone. JBMR 1997 12 (4) : 509 21.
5. Seeman E. Editorial: Growth in bone mass and size - Are racial and gender differences in bone mineral density more apparent than real? J. Clin. Endocrinol. Metab. 1998 83 : 1414 19.
6. Seeman E. Clinical review 137. Sexual dimorphism in skeletal size, density and strength. J. Clin. Endocrinol. Metab. 2001 86 : 4576 84.
7. Eastell R, Reid DM, Compston J et al. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: An update. J. Intern. Med. 1998 244 (4 271 92.
8. Steelman J, Zeitler P. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J. Pediatr. 2003 142 (4 417 23.
9. Bianchi ML, Cimaz R, Bardare M et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children. Arthritis Rheum. 2000 43 : 1960 66.
10. Zacharin MR. Current advances in bone health of disabled children. Curr. Opin. Pediatr. 2004 16 : 545 51.
11. van Rijn RR, van der Sluis IM, Link TM et al. Bone densitometry in children: A critical appraisal. Eur. Radiol. 2003 13 (4 700 10. Epub: 11 Sep 2002.
12. Theintz G, Buchs B, Rizzoli R et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J. Clin. Endocrinol. Metab. 1992 75 (4 1060 65.
13. Henry YM, Fatayerji D, Eastell R. Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: Relative contributions of bone size and volumetric bone mineral density. Osteoporos. Int. 2004 15 (4 263 73. Epub: 24 Feb 2004.
14. Soyka LA, Fairfield WP, Klibanski A. Clinical review 117: Hormonal determinants and disorders of peak bone mass in children. J. Clin. Endocrinol. Metab. 2000 85 (11 3951 63.
15. Hogler W, Briody J, Woodhead HJ, Chan A, Cowell CT. Importance of lean mass in the interpretation of total body densitometry in children and adolescents. J. Pediatr. 2003 143 (1 81 8.
16. Leonard MB, Shults J, Elliott DM, Stallings VA, Zemel BS. Interpretation of whole body dual energy X-ray absorptiometry measures in children: Comparison with peripheral quantitative computed tomography. Bone 2004 34 (6 1044 52.
17. Glastre C, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD. Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: Correlations with growth parameters. J. Clin. Endocrinol. Metab. 1990 70 (5 1330 33.
18. Rubin K, Schirduan V, Gendreau P, Sarfarazi M, Mendola R, Dalsky G. Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty. J. Pediatr. 1993 123 (6 863 70.
19. Makitie O, Doria AS, Henriques F et al. Radiographic vertebral morphology: A diagnostic tool in pediatric osteoporosis. J. Pediatr. 2005 146 (3 395 401.
20. Heaney RP, Abrams S, Dawson-Hughes B et al. Peak bone mass. Osteoporos. Int. 2000 11 (12 985 1009.
21. Hochberg Z. Mechanisms of steroid impairment of growth. Horm. Res. 2002 58 (Suppl. 1 33 8.
22. Hsueh AJ, Erickson GF. Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells. Steroids 1978 32 (5 639 48.
23. MacAdams MR, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann. Intern. Med. 1986 104 (5 648 51.
24. Mora S, Gilsanz V. Establishment of peak bone mass. Endocrinol. Metab. Clin. North Am. 2003 32 (1 39 63.
25. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 2002 37 (2 192 9.
26. Colette C, Monnier L, Pares Herbute N, Blotman F, Mirouze J. Calcium absorption in corticoid treated subjects effects of a single oral dose of calcitriol. Horm. Metab. Res. 1987 19 (7 335 8.
27. Vardi P, Benderly A, Etzioni A, Levy J, Hochberg Z. Hypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-alpha-hydroxyvitamin D3. Eur. J. Pediatr. 1985 144 (3 280 82.
28. Nielsen HK, Thomsen K, Eriksen EF, Charles P, Storm T, Mosekilde L. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Miner. 1988 4 (1 105 13.
29. Inao S, Conrad HE. Coordinate inhibition of alkaline phosphatase and type X collagen syntheses by 1,25-dihydroxyvitamin D3 in primary cultured hypertrophic chondrocytes. Calcif. Tissue Int. 1992 50 (5 445 50.
30. Kato Y, Shimazu A, Iwamoto M et al. Role of 1,25-dihydroxycholecalciferol in growth-plate cartilage: Inhibition of terminal differentiation of chondrocytes in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 1990 87 (17 6522 6.
31. Cheng S, Tylavsky F, Kroger H et al. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am. J. Clin. Nutr. 2003 78 (3 485 92.
32. Dempster DW. Bone histomorphometry in glucocorticoid-induced osteoporosis. J. Bone Miner. Res. 1989 4 (2 137 41.
33. Pereira RM, Delany AM, Canalis E. Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture. Bone 2001 28 (5 484 90.
34. Zhang W, Watson CE, Liu C, Williams KJ, Werth VP. Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: A molecular mechanism contributing to organ atrophy. Biochem. J. 2000 349 (Pt 1 91 7.
35. Bernstein CN, Leslie WD. The pathophysiology of bone disease in gastrointestinal disease. Eur. J. Gastroenterol. Hepatol. 2003 15 : 857 64.
36. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: Comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br. Med. J. (Clin. Res. Ed.) 1986 293 (6560 1463 6.
37. Vestergaard P. Bone loss associated with gastrointestinal disease: Prevalence and pathogenesis. Eur. J. Gastroenterol. Hepatol. 2003 15 (8 851 6.
38. Adler RA, Hochberg MC. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs. Arch. Intern. Med. 2003 163 (21 2619 24.
39. American College of Rheumatology Ad Hoc Committee on Glucocorticoid Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid induced osteoporosis: 2001 update. Arthritis Rheum. 2001 44 : 1496 1503.
40. Homik J, Suarez-Almazor ME, Shea B, Cranney A, Wells G, Tugwell P. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst. Rev. 2000 2 : CD000952 (Review).
41. Homik J, Cranney A, Shea B et al. Bisphosphonates for steroid induced osteoporosis. Cochrane Database Syst. Rev. 2000 2 : CD001347 (Review).
42. Moyeur-Mileur LJ, Xie B, Ball SD, Pratt T. Bone mass and density response to a 12 month trial of calcium and Vitamin D supplement in preadolescent girls. J. Muskuloskel. Neuron Interact. 2003 3 : 63 70.
43. Zhu K, Greenfield H, Du X, Zhang Q, Fraser DR. Effects of milk supplementation on cortical bone gain in Chinese girls aged 10-12 years. Asia Pacif. J. Clin. Nutr. 2003 12 (Suppl. S47
44. Stear SJ, Prentice A, Joners SC et al. Effect of a calcium and exercise intervention on the bone mineral status of 16-18 y old adolescent girls. Am. J. Clin. Nutr. 2003 77 : 985 92.
45. Iuliano-Burns S, Saxon L, Naughton G, Gibbons K, Bass SL. Regional specificity of exercise and calcium during skeletal growth in girls: A randomized controlled trial. J. Bone Miner. Res. 2003 18 (1 156 62.
46. Sambrook PN, Kotowicz M, Nash P et al. Prevention and treatment of glucocorticoid-induced osteoporosis: A comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J. Bone Miner. Res. 2003 18 (5 919 24.
47. Wu-Wong JR, Tian J, Goltzman D. Vitamin D analogs as therapeutic agents: A clinical study update. Curr. Opin. Investig. Drugs 2004 5 (3 320 26.
48. Adams Hillard PJ, Nelson LM. Adolescent girls: The menstrual cycle and bone health. J.Pediatr.Endocrinol. Metab. 2003 3 : 673 81.
49. Zacharin M. Use of androgens and oestrogens in adolescents - A review of hormone replacement treatment. J. Pediatr. Endocrinol. Metab. 2000 13 (1 3 11.
50. Prentice A. Diet, nutrition and the prevention of osteoporosis. Public Health Nutr. 2004 7 (1A 227 43.
51. Bass S, Pearce G, Bradney M et al. Exercise before puberty may confer residual benefits in bone density in adulthood: Studies in active prepubertal and retired female gymnasts. J. Bone Miner. Res. 1998 13 (3 500 7.
52. MacKelvie KJ, Khan KM, Petit MA, Janssen PA, McKay HA. A school-based exercise intervention elicits substantial bone health benefits: A 2-year randomized controlled trial in girls. Pediatrics 2003 112 (6 Pt 1 e447.
53. MacKelvie KJ, Petit MA, Khan KM, Beck TJ, McKay HA. Bone mass and structure are enhanced following a 2-year randomized controlled trial of exercise in prepubertal boys. Bone 2004 34 (4 755 64.
54. Seelander K, Lehenkari P, Väänänen HK. The effects of bisphosphonates on the resorption cycle of isolated osteoclasts. Calcif. Tissue Int. 1994 55 : 368 75.
55. Reinholz GG, Getz B, Pederson L et al. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res. 2000 60 (21 6001 7.
56. Adachi JD, Saag KG, Delmas PD et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum. 2001 44 (1 202 11.
57. Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: A prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. J. Bone Miner. Res. 2001 16 (1 104 12.
58. Reid DM, Hughes RA, Laan RF et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J. Bone Miner. Res. 2000 15 (6 1006 13.